InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,346.56
(
-1.84%
)
US TECH 100
17,898.80
(
-2.65%
)
Dow Jones
39,737.26
(
-1.51%
)
Brent Oil
77.36
(
0.00%
)
Bitcoin
60,625.95
(
-1.31%
)
Post# of 252777
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120201
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 107474

Thursday, 10/28/2010 10:24:19 PM

Thursday, October 28, 2010 10:24:19 PM

Post# of 252777

VRUS—would a partnership for any of its HCV nukes propel the stock materially higher from the current market cap?

Actually, the only nuke that VRUS is seeking to partner is PSI-7977 (the pyrimidine). VRUS intends to keep PSI-938 (the purine) in-house in order to develop a combination pill consisting of the two nukes.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up